##common.pageHeaderLogo.altText##

Vol. 4 No. 3 (2024)

Cytomegalovirus in Pregnant Woman

Clinical Medicine And Health Research Journal, Vol. 4 No. 3 (2024), 15 May 2024 , Page 915-917
https://doi.org/10.18535/cmhrj.v4i3.358

Abstract

Fourty patients were diagnosed with Cytomegalovirus in pregnant with fever, weariness, and lymphadenitis. ELISA was recycled to check CMV IgG antibodies. A entire of 40 patients sera infested by means of lymphadenitis plus 40 regulator sera joined hip this learning be present calculated in place of IL-17 and IL-1β levels in their blood. The results point to significant transformation amongst patients and control for IL-17, while no difference between them at IL-1β.

How to Cite

Abdul Amir, D. V. H. . (2024). Cytomegalovirus in Pregnant Woman. Clinical Medicine And Health Research Journal, 4(3), 915–917. https://doi.org/10.18535/cmhrj.v4i3.358

Download Citation

References

  • Manicklal, S.; Emery, V.C.; Lazzarotto, T.; Boppana, S.B. and Gupta, R.K. (2013). The “silent” global burden of congenital cytomegalovirus. Clin. Microbiol. Revs. 26: 86–102.
  • Ross, S.A.; Ahmed, A.; Palmer, A.L.; Michaels, M.G.; Sánchez, P.J.; Bernstein, D.I.; Tolan, R.W.; Jr Novak Z, Chowdhury, N.; Fowler, K.B.and Boppana, S.B. (2014). Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J. Infect. Dis. 210:1415–1418.
  • Mor, G.and Cardenas, I. (2010). The immune system in pregnancy: A unique complexity. Am. J. Reprod. Immunol. 63: 425–433.
  • Boppana, S.B.; Rivera, L.B.; Fowler, K.B.; Mach, M.and Britt, W.J. (2001). Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344: 1366–1371.
  • Revello, M.G.; Lazzarotto, T.; Guerra, B.; Spinillo, A.; Ferrazzi, E.; Kustermann, A.; Guaschino, S.; Vergani, P.; Todros, T.and Frusca, T. (2014). A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N. Engl. J. Med. 370: 1316–1326.
  • Barbosa, N.G.; Yamamoto, A.Y.; Duarte, G.; Aragon, D.C.; Fowler, K.B.; Boppana, S.; Britt, W.J.; Mussi-Pinhata, M.M. (2018). Cytomegalovirus shedding in seropositive pregnant women from a high-seroprevalence population: the Brazilian cytomegalovirus hearing and maternal secondary infection study. Clin. Infect. Dis. 67: 743–750.
  • Dar, L.; Pati, S.K.; Patro, A.R.K.; Deorari, A.K.; Rai, S.; Kant, S.; Broor, S.; Fowler, K.B.; Britt, W.J. and Boppana, S.B. (2008). Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr. Infect. Dis. J. 27: 841–843.
  • Mussi-Pinhata, M.M.; Yamamoto, A.Y.; Moura Brito, R.M., de Lima Isaac, M.; de Carvalho e Oliveira, P.F.; Boppana, S. and Britt, W.J. (2009). Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin. Infect. Dis. 49: 522–528.
  • Townsend, C.L.; Forsgren, M.; Ahlfors, K.; Ivarsson, S.-A.; Tookey, P.A. and Peckham, C.S. (2013). Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin. Infect. Dis. 56:1232–1239.
  • van der Sande, M.A.B.; Kaye, S.; Miles, D.J.C.; Waight, P.; Jeffries, D.J.; Ojuola, O.O.; Palmero, M.; Pinder, M.; Ismaili, J.; Flanagan, K.L.; Aveika, A.A.; Zaman, A.; Rowland-Jones, S.; McConkey, S.J.; Hilton, C.; Whittle, H.C. and Marchant, A. (2007). Risk factors for and clinical Outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One 2: e492.
  • Wang, C.; Zhang, X.; Bialek, S. and Cannon, M.J. (2011). Attribution of congenital cytomegalovirus infection to primary versus nonprimary maternal infection. Clin. Infect. Dis. 52: 11-13.
  • Ornoy, A. and Diav-Citrin, O. (2006). Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reproductive Toxicol. 21: 399–409.
  • Mussi-Pinhata, M.M.; Yamamoto, A.Y.; Aragon, D.C.; Duarte, G.; Fowler, K.B.; Boppana, S. and Britt, W.J. (2018). Seroconversion for cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: “The BraCHS Study.” J. Infect. Dis. 218: 1200–1204.
  • Yamamoto, A.Y.; Castellucci, R.C.; Aragon, D.C. and Mussi-Pinhata, M.M. (2013) Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol. Infect. 141: 2187–2191.
  • Yue, F.Y. ; Merchant, A. ; Kovacs, C.M. ; Loutfy, M. ; Persad, D. and Ostrowski, M.A. (2008). Virus-Specific Interleukin-17-Producing CD4+ T Cells Are Detectable in Early Human Immunodeficiency Virus Type 1 Infection. ASM Journals. Journal of Virology. Vol. 82 (13).
  • Kassab, C.; Parker Kerrigan, B.; Caruso, H.; El Enazy, S. and Heimberger, A.B. (2019). Cytokines Immunomodulatory Methods. In: Nervous system Drug Delivery [Internet]. Academic Press. p. 297–334.
  • Zhang J.-M. and An, J. (2007). Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. Spring; 45 (2) : 27-37.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information